Global Ocular Inserts Market Research Report 2025

Publication ID:

PB502251493

Publication Date:

February 18, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Ocular Inserts was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ocular Inserts, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Inserts.
The Ocular Inserts market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ocular Inserts market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Inserts manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novartis
Bausch + Lomb
Ocular Therapeutix
EyeGate
Bausch Health
Taiwan Liposome
Graybug Vision
Clearside Biomedical
Alimera Sciences
Envisia Therapeutics
Allergan
Segment by Type
Soluble Inserts
Insoluble Inserts
Segment by Application
Hospitals and Clinics
Ambulatory Surgery Center
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Inserts manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ocular Inserts in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Ocular Inserts Market Overview
1.1 Product Definition
1.2 Ocular Inserts by Type
1.2.1 Global Ocular Inserts Market Value Comparison by Type (2024 VS 2031)
1.2.2 Soluble Inserts
1.2.3 Insoluble Inserts
1.3 Ocular Inserts by Application
1.3.1 Global Ocular Inserts Market Value by Application (2024 VS 2031)
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgery Center
1.3.4 Others
1.4 Global Ocular Inserts Market Size Estimates and Forecasts
1.4.1 Global Ocular Inserts Revenue 2020-2031
1.4.2 Global Ocular Inserts Sales 2020-2031
1.4.3 Global Ocular Inserts Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ocular Inserts Market Competition by Manufacturers
2.1 Global Ocular Inserts Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ocular Inserts Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ocular Inserts Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ocular Inserts, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ocular Inserts, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ocular Inserts, Product Type & Application
2.7 Global Key Manufacturers of Ocular Inserts, Date of Enter into This Industry
2.8 Global Ocular Inserts Market Competitive Situation and Trends
2.8.1 Global Ocular Inserts Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ocular Inserts Players Market Share by Revenue
2.8.3 Global Ocular Inserts Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ocular Inserts Market Scenario by Region
3.1 Global Ocular Inserts Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ocular Inserts Sales by Region: 2020-2031
3.2.1 Global Ocular Inserts Sales by Region: 2020-2025
3.2.2 Global Ocular Inserts Sales by Region: 2026-2031
3.3 Global Ocular Inserts Revenue by Region: 2020-2031
3.3.1 Global Ocular Inserts Revenue by Region: 2020-2025
3.3.2 Global Ocular Inserts Revenue by Region: 2026-2031
3.4 North America Ocular Inserts Market Facts & Figures by Country
3.4.1 North America Ocular Inserts Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ocular Inserts Sales by Country (2020-2031)
3.4.3 North America Ocular Inserts Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ocular Inserts Market Facts & Figures by Country
3.5.1 Europe Ocular Inserts Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ocular Inserts Sales by Country (2020-2031)
3.5.3 Europe Ocular Inserts Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ocular Inserts Market Facts & Figures by Region
3.6.1 Asia Pacific Ocular Inserts Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ocular Inserts Sales by Region (2020-2031)
3.6.3 Asia Pacific Ocular Inserts Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ocular Inserts Market Facts & Figures by Country
3.7.1 Latin America Ocular Inserts Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ocular Inserts Sales by Country (2020-2031)
3.7.3 Latin America Ocular Inserts Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ocular Inserts Market Facts & Figures by Country
3.8.1 Middle East and Africa Ocular Inserts Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ocular Inserts Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ocular Inserts Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ocular Inserts Sales by Type (2020-2031)
4.1.1 Global Ocular Inserts Sales by Type (2020-2025)
4.1.2 Global Ocular Inserts Sales by Type (2026-2031)
4.1.3 Global Ocular Inserts Sales Market Share by Type (2020-2031)
4.2 Global Ocular Inserts Revenue by Type (2020-2031)
4.2.1 Global Ocular Inserts Revenue by Type (2020-2025)
4.2.2 Global Ocular Inserts Revenue by Type (2026-2031)
4.2.3 Global Ocular Inserts Revenue Market Share by Type (2020-2031)
4.3 Global Ocular Inserts Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ocular Inserts Sales by Application (2020-2031)
5.1.1 Global Ocular Inserts Sales by Application (2020-2025)
5.1.2 Global Ocular Inserts Sales by Application (2026-2031)
5.1.3 Global Ocular Inserts Sales Market Share by Application (2020-2031)
5.2 Global Ocular Inserts Revenue by Application (2020-2031)
5.2.1 Global Ocular Inserts Revenue by Application (2020-2025)
5.2.2 Global Ocular Inserts Revenue by Application (2026-2031)
5.2.3 Global Ocular Inserts Revenue Market Share by Application (2020-2031)
5.3 Global Ocular Inserts Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Ocular Inserts Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Bausch + Lomb
6.2.1 Bausch + Lomb Company Information
6.2.2 Bausch + Lomb Description and Business Overview
6.2.3 Bausch + Lomb Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bausch + Lomb Ocular Inserts Product Portfolio
6.2.5 Bausch + Lomb Recent Developments/Updates
6.3 Ocular Therapeutix
6.3.1 Ocular Therapeutix Company Information
6.3.2 Ocular Therapeutix Description and Business Overview
6.3.3 Ocular Therapeutix Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ocular Therapeutix Ocular Inserts Product Portfolio
6.3.5 Ocular Therapeutix Recent Developments/Updates
6.4 EyeGate
6.4.1 EyeGate Company Information
6.4.2 EyeGate Description and Business Overview
6.4.3 EyeGate Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.4.4 EyeGate Ocular Inserts Product Portfolio
6.4.5 EyeGate Recent Developments/Updates
6.5 Bausch Health
6.5.1 Bausch Health Company Information
6.5.2 Bausch Health Description and Business Overview
6.5.3 Bausch Health Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bausch Health Ocular Inserts Product Portfolio
6.5.5 Bausch Health Recent Developments/Updates
6.6 Taiwan Liposome
6.6.1 Taiwan Liposome Company Information
6.6.2 Taiwan Liposome Description and Business Overview
6.6.3 Taiwan Liposome Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Taiwan Liposome Ocular Inserts Product Portfolio
6.6.5 Taiwan Liposome Recent Developments/Updates
6.7 Graybug Vision
6.7.1 Graybug Vision Company Information
6.7.2 Graybug Vision Description and Business Overview
6.7.3 Graybug Vision Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Graybug Vision Ocular Inserts Product Portfolio
6.7.5 Graybug Vision Recent Developments/Updates
6.8 Clearside Biomedical
6.8.1 Clearside Biomedical Company Information
6.8.2 Clearside Biomedical Description and Business Overview
6.8.3 Clearside Biomedical Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Clearside Biomedical Ocular Inserts Product Portfolio
6.8.5 Clearside Biomedical Recent Developments/Updates
6.9 Alimera Sciences
6.9.1 Alimera Sciences Company Information
6.9.2 Alimera Sciences Description and Business Overview
6.9.3 Alimera Sciences Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Alimera Sciences Ocular Inserts Product Portfolio
6.9.5 Alimera Sciences Recent Developments/Updates
6.10 Envisia Therapeutics
6.10.1 Envisia Therapeutics Company Information
6.10.2 Envisia Therapeutics Description and Business Overview
6.10.3 Envisia Therapeutics Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Envisia Therapeutics Ocular Inserts Product Portfolio
6.10.5 Envisia Therapeutics Recent Developments/Updates
6.11 Allergan
6.11.1 Allergan Company Information
6.11.2 Allergan Description and Business Overview
6.11.3 Allergan Ocular Inserts Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Allergan Ocular Inserts Product Portfolio
6.11.5 Allergan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ocular Inserts Industry Chain Analysis
7.2 Ocular Inserts Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ocular Inserts Production Mode & Process Analysis
7.4 Ocular Inserts Sales and Marketing
7.4.1 Ocular Inserts Sales Channels
7.4.2 Ocular Inserts Distributors
7.5 Ocular Inserts Customer Analysis
8 Ocular Inserts Market Dynamics
8.1 Ocular Inserts Industry Trends
8.2 Ocular Inserts Market Drivers
8.3 Ocular Inserts Market Challenges
8.4 Ocular Inserts Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Novartis
Bausch + Lomb
Ocular Therapeutix
EyeGate
Bausch Health
Taiwan Liposome
Graybug Vision
Clearside Biomedical
Alimera Sciences
Envisia Therapeutics
Allergan

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂